ABSTRACT: Heterotopic ossification (HO) is the abnormal formation of bone in soft tissue. Current diagnostics have low sensitivity or specificity to incremental progression of mineralization, especially at early time points. Without accurate and reliable early diagnosis and intervention, HO progression often results in incapacitating conditions of limited range of motion, nerve entrapment, and pain. We hypothesized that non-invasive near-infrared (NIR) optical imaging can detect HO at early time points and monitor heterotopic bone turnover longitudinally. C57BL6 mice received an Achilles tenotomy on their left hind limb in combination with a dorsal burn or sham procedure. A calcium-chelating tetracycline derivative (IRDye 680RD BoneTag) was injected bi-weekly and imaged via NIR to measure accumulative fluorescence for 11 wk and compared to in vivo microCT images. Percent retention of fluorescence was calculated longitudinally to assess temporal bone resorption. NIR detected HO as early as five days and revealed a temporal response in HO formation and turnover. MicroCT could not detect HO until 5 wk. Confocal microscopy confirmed fluorophore localization to areas of HO. These findings demonstrate the ability of a near-infrared optical imaging strategy to accurately and reliably detect and monitor HO in a murine model. ß
Heterotopic ossification (HO) is a debilitating condition resulting in abnormal formation of bone in soft tissue. Common causes include trauma, burns, orthopaedic surgery, traumatic brain injury, or a combination of these events. 1, 2 Without accurate and reliable early diagnosis and intervention, progression often results in joint contractures, nerve entrapment, and pain. 1, 2 Resolution of HO requires invasive surgery, leaving >75% of patients with functional deficits. 2 Early intervention combined with common prophylactic treatments such as NSAIDs or single dose radiation therapy [3] [4] [5] [6] protects against recurrence of HO formation, in addition to an easier surgery, quicker, more effective rehabilitation, and improved viability of surrounding tissue. 7, 8 Therefore, the development of a sensitive diagnostic modality that can detect HO at early time points would greatly improve clinical care of HO patients.
Radiographic techniques, including computed tomography (CT) and magnetic resonance imaging (MRI), provide high resolution visualization of late stage HO; however, they have low sensitivity to incremental progression of mineralization and difficulty differentiating HO from surrounding soft tissue, especially early. [9] [10] [11] [12] Combined MRI and CT aids in the early diagnosis of HO; however, this relies on a "wait and see" approach to monitor changes in mineralization over time, which may be unsuitable for diagnosing cases where progression can be detrimental. 13 CT and MRI can also be time-consuming and expensive, particularly in longitudinal imaging.
Three-phase bone scintigraphy (SPECT) is used for early HO detection. 2 However, presence of inflammation or callus formation, which commonly accompany ectopic bone formation, may cause false positives during normal tissue healing when HO is not present and a high level of variability. 14, 15 The absolute quantification of SPECT signals is complicated by factors including photon scatter and attenuation, necessitating complex corrective algorithms. 16 Ultrasound can detect HO sooner than conventional radiography, but cannot distinguish new bone formation from less mineralized mature bone. 17, 18 Therefore, the capability to accurately diagnose HO formation and progression would ensure the greatest benefit of treatment therapies and minimize complications from unnecessary prophylaxis. Non-invasive near-infrared (NIR) fluorescence imaging modalities have the potential to diagnose bone mineralization and bone turnover at multiple time points. 19 NIR can achieve high tissue penetration of light and low tissue autofluorescence within the NIR spectrum 20 and allows for the visualization of multiple contrast agents at nanomolar levels. 21 NIR imaging techniques have been used to monitor exogenous contrast agents associated with bone mineralization, resorption, and skeletal drug delivery in rodent models of development, repair, and disease, 19, 22, 23 and advanced techniques are currently being investigated for humans. 24 HO is believed to be formed primarily in the context of endochondral ossification. Currently, animal models exist for studying HO, but many rely on implantation of osteogenic cells or media implanted in the soft tissue, which is not analogous to the clinical scenario. Therefore, a mouse model that is similar to the causation of clinical HO was utilized. This model involves local tendon damage and systemic inflammation caused by a burn, which are both common causes of HO, and results in spontaneous HO formation. 1, 25 We evaluated the ability of NIR imaging to noninvasively monitor the progression of HO in vivo in a mouse model.
METHODS

Experimental Design
Seven to eight week old male C57BL6 mice underwent a unilateral Achilles tenotomy with or without an accompanying dorsal partial thickness burn injury (N ¼ 7/group). The burn injury consisted of immersion of 30% of the mouse dorsum in a water bath for 18 s (sham ¼ 30˚C, burn ¼ 60˚C). This procedure accelerates HO formation at the tenotomy site. 26 HO was then measured longitudinally using NIR optical imaging and microCT for 11 wk. Findings were confirmed via endpoint histology. All studies were approved by the University of Michigan Committee on Use and Care of Animals.
Assessment of Probe Specificity and Distribution
To assess the optimal timing for fluorescent imaging probe delivery, longitudinal imaging was performed on three 10 wk-old female Balb/C mice injected with a cocktail of IRDye 680RD BoneTag (160 nmoles/kg; LI-COR Biosciences, Lincoln NE) and IRDye 800 CW Carboxylate (80 nmoles/kg; LI-COR Biosciences). The former probe is an NIR calciumchelating tetracyline derivative with maximum wavelengths of 675 nm absorption and 697 emission. 27 The latter probe is a spectrally distinct (774 nm absorption/788 nm emission), non-reactive control dye used to assess non-specific clearance through the bloodstream and tissues. Mice were imaged as described below at baseline, prior to injection, and subsequently at 5 min and 2, 6, 12, 24, 48, and 72 h to assess BoneTag binding versus non-specific vascular perfusion at the proximal tibia.
In Vivo Near-Infrared Optical Imaging of Heterotopic Ossification At 5 days, and every 2 wk following for 11 wk, mice received 80 nmole/kg of IRDye 680RD BoneTag (LI-COR Biosciences) in 100 mL PBS via tail-vein injection while anesthetized. This contrast agent is an NIR calcium-chelating tetracycline derivative, with maximum wavelengths of 675 nm absorption and 697 nm emission. 27 Prior to each injection, mice were imaged using a multi-spectral acquisition system (Pearl Impulse, LI-COR Biosciences, 685 nm excitation) to quantify baseline levels of tissue fluorescence. Mice were subsequently imaged 24 hrs post-injection to quantify the amount of newly-bound BoneTag fluorophore at each time point.
HO was assessed by measuring total fluorescence of BoneTag in regions of interest of the posterior calcaneus and mid-tibia. Regions of interest were identified on brightfield images and then overlaid on fluorescence images to quantify the total fluorescence for each specimen, as a sum of the fluorescence in the posterior calcaneus and mid-tibia. The amount of fluorescence present before injection was subtracted from the amount measured 24 hrs after injection to quantify the amount of probe delivered for each 2 wk time period. The Accumulative Fluorescence through the duration of the study was calculated by summing the fluorescence at each time point and used as a surrogate marker for how much total heterotopic bone was formed (Equation 1). To assess temporal resorptive activity, Percent Retention of the BoneTag fluorophore during each 2 wk period was calculated by subtracting the amount of retained fluorophore measured in the pre-injection image from the post-injection image of the previous time point (Equation 2).
In Vivo MicroCT While still anesthetized, mice were imaged using microCT (GE Healthcare Pre-Clinical Imaging, London, Ontario).
Images were reconstructed at an isotropic voxel size of 45 mm and calibrated for densitometry. Regions of interest analogous to those used for NIR focused on the distal calcaneus and mid-tibia and were isolated and assessed (MicroView v2.2, GE Healthcare Pre-Clinical Imaging) to measure HO volume independent of pre-existing native bone. A global threshold of 1000 Hounsfield Units was applied for assessment.
Ex Vivo Near-Infrared Optical Imaging At 11 wk, mice were euthanized, and tibiae and calcanei were removed together, minimally dissected, and imaged by NIR (Pearl Impulse, LI-COR Biosciences). Regions of interests akin to those used to assess the in vivo NIR images were used to measure HO ex vivo.
Ex Vivo MicroCT
Tibia and calcanei were then analyzed by microCT (eXplore Locus SP, GE Healthcare Pre-Clinical Imaging). Specimens were immersed in water and scanned two at a time using the Parker method (180˚plus a 20˚fan angle) of rotation at 80 kVp and 80 mA with added filtration in the form of both an acrylic beam flattener and a 0.02 inch aluminum filter. Images were reconstructed at 18 mm voxel size and calibrated for densitometry.
Histology
To examine probe localization within the HO sites, tibiae and calcanei were fixed in 10% NBF for 24 hrs, dehydrated in 70% EtOH, processed, and embedded in PMMA as previously described. 28 Thick sections were cut (EXAKT 300 CP, EXAKT Technologies, Inc. Norerstedt, Germany) and polished to a thickness of $250 mm (EXAKT 400 Micro Grinding System, EXAKT Technologies). Images of probe localization in HO and in normal cortical and trabecular bone were taken using confocal microscopy (Leica Upright SP5X Confocal Microscope, Leica Microsystems, Wetzlar, Germany) with 10x objectives. Images from 3 consecutive sections were taken to confirm consistency. The same sections were then stained with toluidine blue to confirm tissue general tissue features. 29 
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Data Analysis HO progression and probe resorption over the 11 wk time course measured by accumulative fluorescence and percent of fluorophore retention and bone volume measured by microCT were assessed by mixed model and within-sample repeated measures ANOVA followed by Bonferroni post-hoc tests. A linear regression was conducted to determine ability of microCT bone volume to predict in-vivo NIR fluorescence accumulation. Data are presented as mean AE std dev. All data were analyzed using IBM SPSS Statistics V.21 (SPSS, Inc., Chicago, IL. Significance was represented as p < 0.05 unless stated otherwise.
RESULTS
Probe Distribution
Vascular perfusion of BoneTag680 and the carboxylated control probe was rapid, with significant proximal tibial signal within 5 min of injection (Fig. 1) . IRDye 800CW signal subsequently declined between 5 min and 12 h, demonstrating rapid vascular clearance. In contrast, BoneTag signal peaked at 2 h, and then gradually declined to stable levels by 24 hrs postinjection, where signal remains $70 times that of the carboxylated control (Fig. 1) . These findings indicated 24 h as an optimal time for imaging post-injection.
In Vivo NIR Optical Imaging
In vivo NIR imaging revealed ectopic bone formation as early as 5 days in tenotomized limbs of burn and sham groups as compared to their contralateral controls, which progressed temporally at each time point ( Fig. 2A,B) . A significant difference in ossification between the 60˚burn and 30˚sham groups was observed at 5 wk, with a trend towards differences at 7, 9, and 11 wk (p < 0.10). Progression of HO was evident in the temporal NIR imaging sequence (Fig. 3) , where both calcaneal and mid-soleus HO could be seen early on in the 60˚group, and later in the 30˚animals. Non-specific probe accumulation was evident in contralateral limbs of mice from both groups in the ankle, foot, and proximal tibial growth plates, with background levels well below those of operated limbs.
In addition to newly forming HO, local bone resorption was also temporal in nature. There was a decrease in fluorophore retention between 5 days and 3 wk compared to percent retention from 5 wk and beyond (Fig. 4A) . This decrease retention is suggestive of an increase in resorptive activity between 5 days and 3 wk compared to 5 wk and beyond in the tenotomized limbs. Non-operated control limbs showed stable fluorophore retention, reflecting stability of turnover at non-HO sites (Fig. 4B) .
In Vivo MicroCT
In vivo microCT was unable to detect HO until 5 wk, beyond which temporal progression of HO was consistent with that observed by in vivo NIR imaging (Fig. 2C) . The response to the systemic inflammatory burn also produced an increase in HO bone volume at 5, 7, and 9 wk as compared to the tenotomy only group. Beyond 5 wk, microCT was predictive of accumulative fluorescence as a measurement of HO (r 2 ¼ 0.63, p < 0.0005, Fig. 2D ).
Ex Vivo Imaging and Histologic Assessment
High resolution ex vivo NIR optical imaging confirmed high probe accumulation at the posterior calcaneus and mid-soleus, consistent with ex vivo microCT scans (Fig. 5) . Confocal microscopy revealed BoneTag probe within mature cortical bone and in areas of HO. Midtibial HO was woven and unorganized in nature (Fig. 6A-C) in contrast to the well-organized sequential labeling of the tibia (Fig. 6D, E) . Toluidine blue staining confirmed mineralized bone tissue distinct from surrounding soft tissues.
Microscopic imaging of the bound BoneTag fluorophore to the HO posterior to the calcaneous was highly unorganized and trabecular in nature (Fig. 6F, H) . Consistently across specimens, a "shell" of mature bone with trabecular-like woven bone inside was observed (Fig. 6F, G) . These trabecular spicules were labeled with one or two distinct lines of BoneTag, reflecting the high turnover at this site. Conversely, fluorescence labeling of the posterior calcaneus was well organized and sequential in nature (Fig. 6J) . Toluidine blue staining showed the distinction between mineralized bone tissue, surrounding soft tissues, and non-mineralized tissue within the HO regions of interest (Fig. 6G, I , K).
DISCUSSION
In a mouse model of HO, longitudinal NIR imaging revealed increased accumulative fluorescence in teno- tomized limbs at sites of extraskeletal bone formation compared to contralateral control limbs. Furthermore, NIR could differentiate the acceleration of HO in mice receiving an isolated dorsal burn at 5 wk post-injury.
Interestingly, NIR could detect heterotopic mineralization earlier than microCT, which even at a resolution 20X greater than that used clinically 21 was unable to detect HO formation above mineralized thresholds OPTICAL IMAGING OF HETEROTOPIC OSSIFICATION until 5 wk in our model. This inability of radiography to detect HO at early time points is analogous to the clinical setting, where radiographic techniques are of limited utility in the early detection of HO formation. These detection limits could likely be improved with increased radiographic image resolution, but this may require greater associated radiation exposure and longer scan times, limiting the potential gains in image fidelity. Here, NIR could detect small amounts of early mineralization prior to our CT measures, consistent with our prior work using non-invasive Raman spectroscopy to detect early mineralization changes associated with HO in this same model. 26 Together, these findings suggest a benefit for optical technologies at assessing either chemical changes or focal mineralization through exogenous contrast agents associated with HO. Fluorochrome-labeled biopsies have been used to monitor heterotopic ossification progression histology. 30 By using a tetracycline derivative with wavelengths shifted to the near-infrared, we have expanded the ability to detect HO to in vivo by imaging at wavelengths that have increased tissue penetration in the context of reduced background autofluorescence. 20 Confocal microscopy validated our in vivo observations. The NIR probe localized to areas of HO, but was also distributed throughout the existing ossified tissue. Labeling of HO revealed a woven and disorganized bone appearance, while neighboring mid-tibial and posterior calcaneal bone demonstrated a well-organized lamellar bone with multiple sequential labels, reflecting the continued growth of these animals over the entire 11 wk. This non-HO labeling was apparent in contralateral limbs, where fluorophore accumulated due to the animal growth, but remained less than tenotomy limbs as HO progressed.
Currently, the underlying molecular mechanisms responsible for HO are not well understood, but an increase in BMP levels is thought to cause mesenchymal stem cells to differentiate down osteogenic and chondrogenic lineages, thus stimulating endochondral ossification at non-bone sites, dependent on the native tissue. In addition to the progressive mineralization found at our HO sites, we observed dynamic turnover of HO at early time points. Previous work showed that HO results from increased inflammation in this model, 26, 31 and in the present study we found HO to be accelerated when tenotomy was accompanied by burn at sites distant from the tenotomy injury. Few studies have looked at the resorptive activity associated with HO, 32 and due to the longitudinal nature of our study, we were unable to assess histology or endpoint imaging at early time points. Interestingly, the inflammato- OPTICAL IMAGING OF HETEROTOPIC OSSIFICATION ry markers IL-6 and TNF-a, which are both elevated at early time points in HO, 31, 33 were also shown to synergistically increase osteoclast differentiation and resorption. 34 The early loss of fluorescence in limbs subject to tenotomy, but not contralateral controls, may reflect an early turnover phenotype in this model that subsequently stabilizes as HO progresses. Further investigation into the physiological mechanisms underlying this dynamic turnover may provide insight into novel treatment therapies designed to interrupt this early remodeling process. Significantly, the early detection potential for this model allows for further investigations into both the formation and resorption mechanisms responsible for HO, which could lend insight into potential future therapy options.
Previous studies using this contrast agent demonstrated a linear increase in fluorescence signal with increasing doses in vivo and in vitro without signal saturation 27 , suggesting ability to quantify HO, particularly at the low levels of mineralization when HO identification is most challenging. Translation to the clinic may require alternative visualization approaches, since traditional planar fluorescence imaging of NIR agents is restricted to several millimeters of tissue depth due to light penetration limitations and non-linear relationships between signal strength, depth of probe, and optical properties of the tissue. 35 Therefore, the use of handheld devices relying on planar illumination and imaging may be limited to sites nearest the skin surface, or during intraoperative procedures where NIR-guided imaging for resection of mineralization could be used in an open surgical site. 36 Similarly, advances in catheter-based imaging for arthroscopic/endoscopic diagnosis of HO formation could allow a clinician to bring the excitation source and detection hardware to sites of interest in a minimally invasive manner. 37 Lastly, photoacoustic imaging, which relies on ultrasound detection of thermal expansion events associated with fluorophore excitation, reduces the susceptibility to penetration depth artifacts, and recent work showed resolution detection up to 0.1 mm in pre-clinical models. 38 Using any of these techniques, the patient would be injected with a bone-specific fluorophore, and then imaged for easier, earlier resection of the HO, bypassing the tissue penetration limitations associated with optical imaging. In summary, our findings suggest NIR contrast agents may be beneficial to the early detection of HO formation and subsequent monitoring of HO turnover, and may provide a sensitive and reliable approach to detection and monitoring of HO progression and therapy.
